MEREDITH HARDT: Open Payments
NPI 1073183240 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,556 in 127 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $2,556
Food & beverage: $2,556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $406 |
| Janssen Biotech, Inc. | 19 | $323 |
| QOL Medical, LLC | 7 | $241 |
| Madrigal Pharmaceuticals | 10 | $199 |
| Ipsen Biopharmaceuticals, Inc | 8 | $195 |
| Ardelyx, Inc. | 7 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $163 |
| Regeneron Healthcare Solutions, Inc. | 5 | $133 |
| GENZYME CORPORATION | 5 | $117 |
| Lilly USA, LLC | 5 | $91 |
Products named: TREMFYA, DUPIXENT, Sucraid, REZDIFFRA, IQIRVO, MAVYRET, IBSRELA, ENTYVIO.
Industry payments across AZ — which companies pay providers there.
